| HOME >> BIOLOGY >> TECHNOLOGY |
AKRON, Ohio, Feb. 7, 2013 /PRNewswire-USNewswire/ -- Proven technology entrepreneur and executive Vince Kazmer has been named chief operating officer of the Austen BioInnovation Institute in Akron.
During his career, Kazmer, a Hudson resident, founded four life science companies, including EndoRetics, Interventional Imaging, Copernicus Gene Systems and Ribozyme Pharmaceuticals, which was sold to Merck for more than $1 billion in 2006. Additionally, he was president and CEO of six biotechnology/biomedical companies including a publicly traded company. These companies utilized a variety of technologies, among them a Nobel Prize-winning pharmaceutical technology, MRI technology and non-invasive bariatric treatment for obesity. During his career, Kazmer has developed a wealth of experience transferring university technologies into the business world.
"Mr. Kazmer is performance oriented and has regard for both our short- and long-term horizons," said Dr. Frank L. Douglas , ABIA President and CEO. "He has a proven track record in numerous aspects of building successful companies from fund raising and public offerings to business development and intellectual property agreements. He is the ideal leader to help ABIA build upon the culture of entrepreneurial-based innovation, economic development and sustainable growth."
Kazmer's fundraising background includes closing four equity financing rounds from venture capital, angel and public sources totaling more than $30 million, as well as, traditional finance mechanisms and grants.
"I was attracted to ABIA because of the uniqueness of the institute and its partnership. I'm eager to aid in the growth of ABIA, and be a vital part of an emerging leader in life science discovery and commercialization," Kazmer said.
Kazmer earned his master's in business administration at Stanford University an
'/>"/>
| SOURCE Austen BioInnovation Institute in Akron Copyright©2012 PR Newswire. All rights reserved |